Oral Iron for Children with Chronic Kidney Disease
Phase 4
40
about 9.7 years
1–21
2 sites in NY, PA
What this study is about
This trial is testing whether oral iron helps children with chronic kidney disease (CKD) and mild anemia. Eligible children will receive either standard iron therapy or no treatment for 3 months, and outcomes like muscle strength, physical activity, and eating habits will be measured at the start and end of the trial.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Ferrous Sulfate
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
ferrous sulfate
oral (Extended Release Oral Tablet)
Primary: Change in muscle strength
Secondary: Change in quality of life: PROMIS
Renal